Par Drugs and Chemicals Ltd
NSE:PAR

Watchlist Manager
Par Drugs and Chemicals Ltd Logo
Par Drugs and Chemicals Ltd
NSE:PAR
Watchlist
Price: 101.13 INR -0.17% Market Closed
Market Cap: 1.2B INR

Net Margin
Par Drugs and Chemicals Ltd

13.6%
Current
13%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13.6%
=
Net Income
141.8m
/
Revenue
1B

Net Margin Across Competitors

No Stocks Found

Par Drugs and Chemicals Ltd
Glance View

Market Cap
1.2B INR
Industry
Pharmaceuticals

Par Drugs & Chemicals Ltd. engages in the development and manufacture of Active Pharma Ingredients (API) for the domestic market as well as for exports to international markets. The company is headquartered in Bhavnagar, Gujarat. The company went IPO on 2019-05-16. The firm also produces a range of antacid molecules. The Company’s products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide and sucralfate USP. The firm owns and operates its manufacturing facilities at Bhavnagar in Gujarat. The company has over four manufacturing blocks at Bhavnagar, which are for different products having a capacity of approximately 9,700 metric tons per annum.

PAR Intrinsic Value
147.31 INR
Undervaluation 31%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13.6%
=
Net Income
141.8m
/
Revenue
1B
What is the Net Margin of Par Drugs and Chemicals Ltd?

Based on Par Drugs and Chemicals Ltd's most recent financial statements, the company has Net Margin of 13.6%.

Back to Top